3,7-dimethyl-1-propargylxanthine has been researched along with n-formylmethionine leucyl-phenylalanine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broussas, M; Cornillet-Lefèbvre, P; Nguyen, P; Potron, G | 1 |
| O'Sullivan, RG; Redmond, HP; Street, JT; Wakai, A; Wang, JH; Winter, DC | 1 |
2 other study(ies) available for 3,7-dimethyl-1-propargylxanthine and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
Inhibition of fMLP-triggered respiratory burst of human monocytes by adenosine: involvement of A3 adenosine receptor.
Topics: Adenosine; Bucladesine; Calcium; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytochalasin B; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Humans; Indoles; Luminescent Measurements; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Oxygen Consumption; Pyrroles; Receptor, Adenosine A3; Receptors, Purinergic P1; Respiratory Burst; RNA, Messenger; Second Messenger Systems; Theobromine; Xanthines | 1999 |
Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); CD18 Antigens; Cell Movement; Cells, Cultured; Chemotaxis, Leukocyte; Depression, Chemical; Dose-Response Relationship, Drug; Endothelial Growth Factors; Endothelium, Vascular; Humans; Intercellular Adhesion Molecule-1; Lymphokines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Theobromine; Tumor Necrosis Factor-alpha; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |